Patents Assigned to ChengDa Pharmaceuticals Co., Ltd.
  • Patent number: 12234234
    Abstract: The invention discloses a method for synthesizing 1,7-naphthyridine derivatives, which relates to the technical field of synthesizing pharmaceutical intermediates and organic chemical intermediates, wherein the method includes: (1) 2-chloro-3-amino-pyridine being used as Compound I as a starting material, and protecting an amino group to prepare Compound II; (2) the Compound II reacting with an aldehydation reagent under alkaline conditions to obtain Compound III; (3) cyclizing the Compound III with acrylate compounds under the action of Lewis acid to prepare compound IV.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: February 25, 2025
    Assignee: ChengDa Pharmaceuticals Co., Ltd.
    Inventors: Wei Qian, Yuhua Shi, Xing Huang, Changming Dong, Junkui Dang, Zhipeng Wang, Yu Feng, Hong Xu, Zongxi Huang, Ye Chen, Huafei Shen, Jun Zhang